Sunshine Biopharma Inc.
SBFM XNAS
$2.02
-0.02 (-0.98%)
▼
15-min delayed
Open
$2.02
High
$2.02
Low
$2.02
Volume
9.9K
Market Cap
$4.33M
About Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $8.09M | $-1,243,869 | $-0.25 |
| FY 2025 | $36.31M | $-5,975,352 | $-1.44 |
| Q3 2025 | $9.42M | $-883,820 | $-0.19 |
| Q2 2025 | $9.41M | $-1,770,834 | $-0.39 |
TickerDaily Coverage
Penny Stocks Under $5 Showing Triple-Digit Gains in May 2026
Penny Stocks
Marcus Rivera · May 31, 2026
May 2026 has delivered some of the most explosive penny stock moves of the year. We break down the...
Stock Market Today, May 22, 2026: Biotech Fever Drives Week of Explosive Gains
Market News
David Brooks · May 22, 2026
Friday, May 22, 2026 closes a volatile week dominated by biotech and small-cap explosions. Sunshine...
Why Is Sunshine Biopharma (SBFM) Stock Up 50.3% Today?
Penny Stocks
Marcus Rivera · May 21, 2026
Sunshine Biopharma (SBFM) stock ripped 50.3% higher Thursday on explosive volume, crushing through...
Why Is Sunshine Biopharma (SBFM) Stock Up 684.9% Today?
Penny Stocks
Marcus Rivera · May 18, 2026
Sunshine Biopharma (SBFM) stock ripped 684.9% Monday, May 18, 2026, closing at $2.23 after a...
View All Coverage →
Get SBFM Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Sunshine Biopharma Inc..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.